Table 12.19 Effects of Haloperidol on Agitation
Author Year Country Research Design PEDro Sample Size |
Methods |
Outcomes |
Rao et al. (1985) USA Case Series N=26 |
Population: Severe TBI; Age Range=16-48 yr. Treatment: Retrospective review of individuals whose agitation was treated with haloperidol (n=11; 2-15 mg/day) and those who were not (n=15). Outcome Measure: Patient Evaluation Conference Systems. |
1. Those treated had a longer length of PTA (p<0.03). 2. No statistically significant differences were shown between those who were and were not treated in terms of independent living at discharge (64% versus 60%, respectively) or independence in managing behaviour (40% versus 60%). 3. 3 of those non treated obtained independence in intellectual skills but none of the treated patients did this. |